rFVIIa in ICH in Patients Treated With Anticoagulants or Anti-Platelets

Recruiting

Phase 2 Results N/A

Summary of Purpose

Evaluation of efficacy and safety of recombinant factor VIIa versus standard therapy in preventing early haematoma growth in spontaneous acute intracerebral haemorrhage in patients treated with oral anticoagulants or antiplatelets agents

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 19 September 2006.

1 Sep 2005 13 Sep 2005 Unavailable 1 Sep 2006 1 Sep 2006 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Single Blind
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts